Rifaximin is a semisynthetic, rifamycin-based non-systematic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is primarily used to treat diarrhea caused by E. coli, but recent studies published in the American Journal of Gastroenterology suggest its efficacy in relieving chronic functional symptoms of bloating and flatulence that are common in gastrointestinal disorders, such as Irritable Bowel Syndrome.

It is currently sold under the brand name Xifaxan® by Salix Pharmaceuticals.

References

---

• Sharara A, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, ElHajj I. A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence. The American Journal of Gastroenterology, 101(2):326 — February 2006.
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Sixth Edition, Wayne PA. — January 2003
• Micromedex information on rifaximin
• FDA label approved for Xifaxan (PDF warning)

More on [ Rifaximin ]

Rifaximin - Twitter Search

induction of clinical response w/ rifaximin in crohn's disease http://bit.ly/4rcdnq
paidtrials (US Clinical Trials) Sat, 12 Dec 2009 16:18:48 -0000
induction of clinical response w/ rifaximin in crohn's disease http://bit.ly/4rcdnq
Google- Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA - News-Medical.net: http://bit.ly/8JLhua
ibsgroup (ibsgroup) Thu, 10 Dec 2009 20:07:13 -0000
Google- Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA - News-Medical.net: http://bit.ly/8JLhua
Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA: Salix Pharmaceuticals, Ltd. today reported tha... http://bit.ly/4sl2ck
NewsMedical (News-Medical.Net) Thu, 10 Dec 2009 15:49:07 -0000
Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA: Salix Pharmaceuticals, Ltd. today reported tha... http://bit.ly/4sl2ck
$SLXP / Salix Pharma Expects to file rifaximin NDA 1H10 / Seeking expanded FDA approval non-CIBS / http://tinyurl.com/ycszmtk
mikehavrilla (Mike Havrilla) Thu, 10 Dec 2009 15:13:16 -0000
$SLXP / Salix Pharma Expects to file rifaximin NDA 1H10 / Seeking expanded FDA approval non-CIBS / http://tinyurl.com/ycszmtk
Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatm... http://bit.ly/5yyp6A
Dr_Raj_Miniyar (Dr. Raj Miniyar) Thu, 10 Dec 2009 14:42:02 -0000
Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatm... http://bit.ly/5yyp6A

Subscribe to Rifaximin RSS feed